<DOC>
	<DOC>NCT01171950</DOC>
	<brief_summary>The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help pediatric patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.</brief_summary>
	<brief_title>CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1. Age 5 years to 16 years, inclusive 2. Inability to wean from cardiopulmonary bypass (CPB) 1. Body weight &lt; 20 kg 2. Severe aortic insufficiency 3. Unrestricted intracardiac communications (i.e. large VSD) 4. Pulmonary vascular resistance index (PVRI) &gt; 10 IU 5. Presence of DIC 6. On hemodialysis (excluding hemofiltration) 7. Contraindications to systemic anticoagulation 8. Active systemic infection unresponsive to antibiotics 9. Unresolved malignancy 10. On other investigational VAS</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Thoratec Corporation</keyword>
</DOC>